Financial Security Advisor Inc. Purchases 685 Shares of Danaher Co. (NYSE:DHR)

Financial Security Advisor Inc. increased its holdings in Danaher Co. (NYSE:DHR) by 26.2% during the third quarter, HoldingsChannel reports. The institutional investor owned 3,302 shares of the conglomerate’s stock after acquiring an additional 685 shares during the quarter. Financial Security Advisor Inc.’s holdings in Danaher were worth $919,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the business. Catalina Capital Group LLC raised its position in Danaher by 11.3% during the third quarter. Catalina Capital Group LLC now owns 3,127 shares of the conglomerate’s stock valued at $869,000 after purchasing an additional 318 shares in the last quarter. Northstar Asset Management Inc. raised its holdings in shares of Danaher by 0.6% during the 3rd quarter. Northstar Asset Management Inc. now owns 34,654 shares of the conglomerate’s stock valued at $9,635,000 after buying an additional 190 shares in the last quarter. Marks Group Wealth Management Inc boosted its stake in Danaher by 5.0% in the third quarter. Marks Group Wealth Management Inc now owns 4,660 shares of the conglomerate’s stock worth $1,296,000 after buying an additional 223 shares in the last quarter. Balentine LLC bought a new position in Danaher during the third quarter valued at approximately $420,000. Finally, Crestwood Advisors Group LLC lifted its holdings in shares of Danaher by 0.4% in the 3rd quarter. Crestwood Advisors Group LLC now owns 333,248 shares of the conglomerate’s stock worth $92,649,000 after acquiring an additional 1,264 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on DHR shares. Stifel Nicolaus lifted their target price on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research report on Wednesday, October 23rd. The Goldman Sachs Group boosted their target price on Danaher from $225.00 to $250.00 and gave the company a “neutral” rating in a research note on Wednesday, July 24th. Barclays decreased their price target on Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 23rd. Royal Bank of Canada cut their target price on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. Finally, Wolfe Research raised shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target for the company in a research report on Thursday, October 31st. Six research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $287.16.

Insiders Place Their Bets

In other news, SVP Georgeann Couchara sold 952 shares of the stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the completion of the sale, the senior vice president now owns 4,212 shares of the company’s stock, valued at $1,130,374.44. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 10.90% of the stock is owned by insiders.

Danaher Stock Up 1.2 %

Danaher stock opened at $250.16 on Wednesday. Danaher Co. has a fifty-two week low of $192.35 and a fifty-two week high of $281.70. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The company has a market cap of $180.68 billion, a PE ratio of 47.74, a PEG ratio of 4.55 and a beta of 0.85. The business’s 50-day simple moving average is $266.16 and its two-hundred day simple moving average is $260.84.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same quarter last year, the business posted $2.02 earnings per share. The business’s quarterly revenue was up 3.1% compared to the same quarter last year. Equities analysts anticipate that Danaher Co. will post 7.51 EPS for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were given a dividend of $0.27 per share. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.43%. Danaher’s payout ratio is 20.61%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.